Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical, Inc. \De\ (LFCR) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to 0.54.

  • Lifecore Biomedical, Inc. \De\'s Asset Utilization Ratio rose 535.08% to 0.54 in Q2 2025 from the same period last year, while for May 2025 it was 0.54, marking a year-over-year increase of 535.08%. This contributed to the annual value of 0.52 for FY2025, which is 336.52% up from last year.
  • As of Q2 2025, Lifecore Biomedical, Inc. \De\'s Asset Utilization Ratio stood at 0.54, which was up 535.08% from 0.53 recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Asset Utilization Ratio ranged from a high of 0.54 in Q2 2025 and a low of 0.24 during Q2 2021
  • Its 5-year average for Asset Utilization Ratio is 0.42, with a median of 0.42 in 2023.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first tumbled by 8311.69% in 2021, then surged by 6584.85% in 2022.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Asset Utilization Ratio (Quarter) stood at 0.28 in 2021, then soared by 44.16% to 0.4 in 2022, then increased by 13.83% to 0.46 in 2023, then grew by 13.97% to 0.52 in 2024, then increased by 3.67% to 0.54 in 2025.
  • Its Asset Utilization Ratio was 0.54 in Q2 2025, compared to 0.53 in Q1 2025 and 0.52 in Q4 2024.